LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis

NeoStrata

Status: Completed

Conditions: Chronic Plaque Psoriasis

Treatments: Drug: LCD; Drug: calcipotriol

Study type: Interventional

Funder types: Industry

Identifiers

NCT00705900

06-LCDPOP

Details and patient eligibility

About

The purpose of this study is to compare the safety and effectiveness of a new topical LCD solution and a commercially available calcipotriol (Vitamin D) cream in reducing the symptoms of plaque psoriasis and improving the quality of life in adults.

Enrollment: 60 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 years of age or older
• able and willing to provide written informed consent
• diagnosed with chronic plaque psoriasis
• 3% to 15% body surface area involved
• in good general health

Exclusion criteria

• other current treatments for psoriasis
• renal or liver dysfunction
• pregnant or nursing

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

60 participants in 2 patient groups

1

Experimental group

Description:

LCD Solution: 2 applications / day

Treatment:

Drug: LCD

2

Active Comparator group

Description:

Calcipotriol cream: 2 applications / day

Treatment:

Drug: calcipotriol